🟢 Cue Biopharma is trading 5% up today as shares extend volatile gains following recent financing and licensing deals

Cue Biopharma is trading at $32.51 (5% up) as shares extend a volatile move following recent financing and licensing news.

• The stock previously spiked nearly 100% after-hours following a $30 million private placement, a new clinical-stage licensing deal, and a CEO change.
• Investors remain focused on dilution risk and profit-taking after an additional $50 million financing and going-concern commentary.